Amanote Research
Register
Sign In
Riboflavin Is a Determinant of Total Homocysteine Plasma Concentrations in End-Stage Renal Disease Patients
Journal of the American Society of Nephrology : JASN
- United States
doi 10.1097/01.asn.0000013299.11876.f6
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Nephrology
Date
May 1, 2002
Authors
S. Skoupy
Publisher
American Society of Nephrology (ASN)
Related search
Plasma Immunoreactive Leptin Concentration in End-Stage Renal Disease
Clinical Science
Medicine
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Kidney International Reports
Nephrology
Pericardial Effusion in Patients With End-Stage Renal Disease
Texas Heart Institute Journal
Medicine
Cardiovascular Medicine
Cardiology
Pulmonary Hypertension in Patients With End-Stage Renal Disease
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
HIV Testing in Patients With End Stage Renal Disease.
BMJ
Periodontal Disease in Chronic Kidney Disease and End-Stage Renal Disease Patients: A Review
CardioRenal Medicine
Urology
Cardiovascular Medicine
Cardiology
Plasma Concentration of Coupling Factor 6 and Cardiovascular Events in Patients With End-Stage Renal Disease
Kidney International
Nephrology
Renal Cell Carcinoma in End-Stage Renal Disease
Plasma Homocysteine Concentrations in Dogs
International Journal of Veterinary Medicine: Research & Reports
